Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 1-25 of 606 matching filings.

Per page
25
Current page
1
4

FORM 4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36421

144 filing

Filing date
05 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-88628

SCHEDULE 13D/A filing

Filing date
04 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36421

144 filing

Filing date
04 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2026
Reporting date
29 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36421

144 filing

Filing date
02 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 May 2026
Reporting date
18 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 May 2026
Reporting date
18 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 May 2026
Reporting date
18 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36421

144 filing

Filing date
11 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36421

144 filing

Filing date
11 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36421

144 filing

Filing date
11 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
11 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36421

DEF 14A

Filing date
21 Apr 2026
Reporting date
03 Jun 2026
Next action
Verify source filing
3

FORM 3

Filing date
02 Apr 2026
Reporting date
23 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Apr 2026
Reporting date
23 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .